Efficacy of Dihydroartemisinin for Treating Acne Vulgaris
ConditionAcne Vulgaris
Trial statusRecruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age18-40
SponsorShanghai Zhongshan Hospital
About this trial
The goal of this clinical trial is to learn if dihydroartemisinin (DHA) works to treat Acne Vulgaris in adults. The main question it aims to answer is:
• Does DHA improve the acne severity by at least one grade after treatment. Researchers will treat patients who are clinically diagnosed as Acne Vulgaris to see if DHA works to alleviate the symptoms of Acne Vulgaris.
Participants will:
* Take DHA every day for 3 months * Visit the clinic once every month for checkups and tests
Eligibility criteria
Qualifiers
Clinically diagnosed with acne vulgaris;
For female patients, no pregnancy plans within the next 6 months.
Disqualifiers
Patients who have used sex hormones or other systemic medications for acne treatment within the past 3 months;
Patients who have used topical medications for acne within the past 2 weeks;
Pregnant or breastfeeding women;
Patients with known severe diseases of vital organs (e.g., heart, liver, kidney) or malignancies.
Trial design
Treatments tested in this trial
- dihydroartemisinin
Treatment groups
60 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov